|
Business andBioethics Seminar in Malmö 15-16.10.2006 Legislation
on biotechnology
|
Business and bioethics, Clarion Collection
Hotel, Malmö, Sweden PROGRAMME and presentations (pdf)
15.00 Registration and coffee 16.00 Opening 16.10-18.30 Session 1. Commercial interests,
science and ethics 16.10 The philosophy
of biobusiness 16.40 How does Novo Nordisk address bioethical
issues 17.10 Refreshments 17.30 Genetic databases
- private versus public interests 19.30 Drinks and dinner
09.00- 12.00 Session 2. Multiple interests 09.00 The ethics
and social responsibility in public research funding 09.30 Private public
partnerships 10.00 From public
resources to commercial goods 10.30 Coffee 10.45 Health Diagnostics:
To whom, what and why? 11.15 Combined
roles, conflict of interest? Comments by Gunna Christiansen, Professor,
University of Aarhus and Tomas Ibsen, Director, Organon 12.00 - 13.00 Lunch 13.00- 15.00 Session 3. Dealing with
conflicting interests 13.00 Commercial
interests versus common goods 13.30 Real new
need and economic possibilities 14.00 Comments by Dag Helland, Professor, University of Bergen and Eero Vuorio, Chairman, National Board of Research Ethics Final discussion 14.45 Closing remarks |